Medicare Enrolled
Dr. Shahryar Yadegar, M.D.
Critical Care Medicine · Tarzana, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yadegar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yadegar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yadegar
Dr. Shahryar Yadegar is a critical care medicine specialist in Tarzana, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Yadegar performed 15,199 Medicare services across 8,409 unique beneficiaries.
Between the years covered by Open Payments, Dr. Yadegar received a total of $12,595 from 54 pharmaceutical and/or device companies across 614 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yadegar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in CA
$12,595 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,199
Medicare services
Top 0% in CA for critical care medicine
8,409
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~800 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,603 | $104 | $230 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
2,066 | $59 | $125 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
1,056 | $28 | $372 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,036 | $74 | $150 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
968 | $32 | $170 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
902 | $40 | $171 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
648 | $15 | $60 |
| New patient office visit, complex (60-74 min) | 576 | $177 | $501 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
568 | $23 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
450 | $95 | $375 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
443 | $39 | $150 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
398 | $44 | $225 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
377 | $169 | $600 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
337 | $8 | $100 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
317 | $52 | $283 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
300 | $33 | $225 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
294 | $50 | $250 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
293 | $47 | $240 |
| Lung volume measurement test A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs. |
291 | $13 | $200 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
290 | $38 | $500 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
268 | $17 | $68 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
254 | $51 | $150 |
| Nitric oxide gas level test A test that measures the level of nitric oxide gas in the body. |
164 | $17 | $286 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
87 | $138 | $650 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
57 | $145 | $351 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
47 | $63 | $285 |
| Initial nursing facility care, high complexity An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes. |
27 | $137 | $175 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
26 | $97 | $950 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
20 | $94 | $700 |
| Additional 30 minutes of critical care This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period. |
13 | $86 | $450 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
12 | $229 | $470 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
11 | $92 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,595
Total received (2018-2024)
Avg $1,799/year across 7 years
Top 11% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
614
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,595 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,159
2023
$2,908
2022
$2,043
2021
$1,044
2020
$944
2019
$1,813
2018
$1,683
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$476
Boehringer Ingelheim Pharmaceuticals, Inc.
$470
GlaxoSmithKline, LLC.
$157
Amgen Inc.
$146
Janssen Pharmaceuticals, Inc
$110
Insmed, Inc.
$81
Grifols USA, LLC
$78
Mylan Specialty L.P.
$76
United Therapeutics Corporation
$60
Inspire Medical Systems, Inc.
$57
GENZYME CORPORATION
$57
Philips North America LLC
$53
Pulmonx Corporation
$44
Electromed, Inc.
$40
Gilead Sciences, Inc.
$32
Shionogi Inc
$30
Merck Sharp & Dohme LLC
$29
Baxter Healthcare
$26
PFIZER INC.
$25
Phadia US Inc.
$25
Ceribell, Inc.
$24
Azurity Pharmaceuticals, Inc.
$22
ANI Pharmaceuticals, Inc.
$21
Vifor Pharma, Inc.
$20
Top 3 companies account for 51.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,962
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,769
GlaxoSmithKline, LLC.
$1,249
Grifols USA, LLC
$675
Amgen Inc.
$492
Philips Electronics North America Corporation
$441
Janssen Pharmaceuticals, Inc
$383
Gilead Sciences, Inc.
$381
Novartis Pharmaceuticals Corporation
$380
Mylan Specialty L.P.
$371
Actelion Pharmaceuticals US, Inc.
$328
Pulmonx Corporation
$311
Sunovion Pharmaceuticals Inc.
$288
Insmed, Inc.
$286
Bayer HealthCare Pharmaceuticals Inc.
$262
PFIZER INC.
$221
Regeneron Healthcare Solutions, Inc.
$211
Inspire Medical Systems, Inc.
$193
Takeda Pharmaceuticals U.S.A., Inc.
$189
United Therapeutics Corporation
$184
E.R. Squibb & Sons, L.L.C.
$175
GENZYME CORPORATION
$166
Baxter Healthcare
$127
Paratek Pharmaceuticals, Inc.
$125
Electromed, Inc.
$117
Intuitive Surgical, Inc.
$115
Merck Sharp & Dohme LLC
$98
ADVANCED RESPIRATORY, INC
$82
Genentech USA, Inc.
$80
Ventec Life Systems, Inc.
$78
Merck Sharp & Dohme Corporation
$75
Phadia US Inc.
$72
Mallinckrodt Hospital Products Inc.
$64
Circassia Pharmaceuticals Inc
$61
Philips North America LLC
$53
Boston Scientific Corporation
$51
Shionogi Inc
$51
Jazz Pharmaceuticals Inc.
$44
JAZZ PHARMACEUTICALS INC.
$38
TETRAPHASE PHARMACEUTICALS, INC.
$35
Neurocrine Biosciences, Inc.
$30
Mallinckrodt Enterprises LLC
$28
PORTOLA PHARMACEUTICALS, INC.
$27
Breas Medical, Inc.
$26
Lilly USA, LLC
$24
Ceribell, Inc.
$24
ACADIA Pharmaceuticals Inc
$22
Azurity Pharmaceuticals, Inc.
$22
ANI Pharmaceuticals, Inc.
$21
Vifor Pharma, Inc.
$20
Advanced Respiratory, Inc
$20
Fisher & Paykel Healthcare Inc
$17
Tactile Systems Technology Inc
$15
Apria Healthcare LLC
$13
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · CHARTIS CATHETER · DAYBUE · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · ELIQUIS · EXALT Model D · Esbriet · FASENRA · Fetroja · Flexitouch Plus · GLASSIA · HORIZANT · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · INGREZZA · INSPIRE · INVOKANA · ImmunoCAP · JARDIANCE · LONHALA MAGNAIR · Medela · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PAXLOVID · POCKET EEG DEVICE · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TALTZ · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · Utibron · Veklury · Vivo 45 LS · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · Xerava · Xolair · Xyrem · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
123
Per 100K population
1.2
County median income
$87,760
Nearest hospital
PROVIDENCE CEDARS SINAI TARZANA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yadegar is a clinical cardiology specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 11% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yadegar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yadegar performed 2,603 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yadegar receive payments from pharmaceutical companies?
Yes. Dr. Yadegar received a total of $12,595 from 54 companies across 614 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yadegar's costs compare to other critical care medicines in Tarzana?
Dr. Yadegar's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yadegar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Tarzana
Browse critical care medicines in Tarzana ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in CA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in CA
Which CA critical care medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology